Urology | Christian Medical College Ludhiana Society (Regd.)Ludhiana
Punjab India, Hospitals & Health Networks, Hospitals for a Healthy Environment,
LifeCare Hospital
An International,
multi-center, open label, randomized study assessing the safety
and efficacy of a monthly dosing regimen of Ozarelix versus
Goserelin Depot (Zoladex®) in men with prostate cancer.
2)
Open label, randomized, multicentric clinical trial of
Mycobacterium w. in combination with Docetaxel versus Docetaxel
in metastatic hormone refractory prostate cancer.
3)
Study of Botox® purified Neurotoxin complex’s placebo
controlled, randomized, safety and effectiveness aspects in
patients with Neurogenic Detrusor Overactivity and Neurological
Respiratory Impairment.
Recently Completed:
1)
A Phase IIb/III,multicenter,double
blind,randomised,placebo-controlled,dose ranging study of
Tamsulosin Hydrochloride(Low,Medium,HighDose) as treatment in
children with Neuropathic bladder.
2)
ZD4054 in Hormone Resistant Prostate Cancer a) A Phase III, randomized, double blind study to assess
the efficacy and safety of 15 mg ZD4054 versus placebo, both
with best supportive care, in patients with Hormone Resistant
Prostate Cancer and Bone metastasis who are pain free or mildly
symptomatic.
b) A Phase III, randomized, double blind study to assess
the efficacy and safety of once daily orally administered ZD4054
15mg in non metastatic Hormone Resistant Prostate cancer
patients.
3)
A Randomized,
double blind, placebo controlled study to evaluate the efficacy
and safety of Fesoterodine as an “Add-On” therapy in men with
persistent overactive bladder symptoms under monotherapy of
Alpha blocker for lower urinary tract symptoms.
4)
A study of
Mycobacterium w. in superficial transitional cell carcinoma of
bladder.
5)
A Phase III study
to assess the tolerability and efficacy of Odanacatib in
prolonging bone metastasis free survival in men with Hormone
Refractory Prostate Cancer.
6)
An Epidemiological
study on prostate cancer –Sponsored by Cancer of Prostate
Endeavour (COPE, India) and ICMR.
7)
A Randomized,
double blind, placebo controlled, phase IIb study to assess
efficacy effects of ART-123 on subjects with sepsis and
disseminated intravascular coagulation.
Christian Medical College Ludhiana Society (Regd.)Ludhiana Punjab India,
Hospitals & Health Networks, Hospitals for a Healthy Environment, LifeCare
Hospital
